Biological evaluation of hydrogenated rapeseed oil

Caprenin 3. Absorption and Caloric Value in Adult Humans

Caprenin is a triglyceride that contains primarily caprylic (C8:0), capric (C10:0), and behenic (C22:0) acids and modest amounts of arachidic (C20:0) and lignoceric (C24:0) acids. Using the fat-balance technique, the absorption of C20:0, C22:0, and C24:0 was measured in 20 healthy adult men and women aged 20–60 years consuming a chocolate-flavored caprenin confection. The absorption values for these very long-chain fatty acids (VLCFAs) were determined based on measurements of their dietary intake and fecal excretion during a 5-day treatment period and a 7-day posttreatment washout period after correcting for baseline excretion of VLCFAs. Each subject consumed 4.7 g C20:0, 52.8 g C22:0, and 0.84 g C24:0 from the test confection during the treatment. Absorption averaged 41.6% ± 3.6% (SEM) for C20:0, 28.8% ± 4.4% for C22:0, and 14.8% ± 3.9% for C24:0. Using a modification of the Atwater method, the physiological fuel value (caloric value) of caprenin was then calculated. This modified method takes into account the partial absorption of VLCFAs and the heat loss due to the metabolism of the medium-chain fatty acids C8:0 and C10:0. The results of this study demonstrate that the caloric value of caprenin is 5 kcal/g compared to the value of 9 kcal/g for other dietary triglycerides.

Caprenin 2. Short-Term Safety and Metabolism in Rats and Hamsters

A series of short-term feeding studies was undertaken to evaluate the biological effects of three behenic medium-chain triglycerides (BMCTs), including caprenin (CAP). All three triglycerides were composed primarily of caprylic (C8:0), capric (C10:0), and behenic (C22:0) acids, although total fatty acids compositions differed slightly. In the first experiment, adult male rats were maintained for 23 days on semipurifled diets containing 26% (w/w) of a BMCT, medium-chain triglyceride (MCT) oil or corn oil. Each triglyceride was assessed for its effects on growth, feed efficiency, calcium and iron balance, fat balance, and carcass fatty acid composition. A 28-day study of similar design evaluated the nutritive properties of chow diets that were supplemented with 15% of a BMCT or MCT when consumed by adult male golden Syrian hamsters. Finally, a 28-day feeding study in weanling male and female rats was conducted to assess the potential oral toxicity of CAP. CAP was administered in semipurifled diet at 0, 5, 10, and 15%. Corn oil was added at 18, 13, 8, and 3%, respectively, to maintain total dietary fat content at 18% and provide a source of essential fatty acids. The overall results of these experiments demonstrated that (1) BMCTs, including CAP, provided usable energy to sustain growth in rats and hamsters, although these triglycerides had lower calorie values than typical fats and oils, (2) up to 75–82% of the behenic acid content of BMCTs was unabsorbed by both species and excreted in the feces, (3) increased fecal excretion of BMCT-derived behenic acid did not significantly affect calcium and iron balance in rats, (4) behenic acid was metabolized readily by both rats and hamsters as indicated by recovery of only 3–15 % of the absorbed fatty acid in total carcass fat at the end of the studies, and (5) CAP was nontoxic to rats when consumed for 28 consecutive days at levels of up to 15% in the diet (83% of total dietary fat).

Caprenin 1. Digestion, Absorption, and Rearrangement in Thoracic Duct-Cannulated Rats

Caprenin (CAP) is a triglyceride that primarily contains caprylic (C8:0), capric (C10:0), and behenic (C22:0) acids. This study was undertaken to determine whether or not CAP is qualitatively digested, absorbed, and rearranged like other dietary fats and oils that contain these medium-chain and very long-chain fatty acids. In vitro results showed that neat CAP, coconut oil (CO) and peanut oil (PO) were hydrolyzed by porcine pancreatic lipase. All of the neat triglycerides also were digested in vivo by both male and female rats. This was shown by the recovery of significantly more extractable lymphatic fat than with fat-free control animals and by the recovery of orally administered triglyceride-derived fatty acids in lymph triglycerides. However, substantially more PO (74%) and CO (51%) were recovered in lymph relative to CAP (10%). These quantitative differences are consistent with the fatty acid composition of each triglyceride and primary routes of fatty acid uptake. The 24-h lymphatic recovery of CAP-derived C8:0, C10:0, and C22:0 averaged 3.9%, 17.8%, and 11.2%, respectively, for male and female rats. The C8:0 and C10:0 results approximated those obtained with CO (2.0% and 16.3%, respectively). In contrast, the 24-h absorbability of C22:0 in CAP was significantly less than that seen in PO (55.4%). Finally, there was no evidence of significant rearrangement of the positions of fatty acids on glycerol during digestion and absorption. Those fatty acids recovered in lymphatic fat tended to occupy the same glyceride positions that they did in the neat administered oils. However, the lymph fats recovered from all animals dosed with fat emulsions were enriched with endogenous lymph fatty acids. It is concluded that CAP is qualitatively digested, absorbed, and processed like any dietary fat or oil that contains medium-chain and very long-chain fatty acids.

The absorption of stearic acid from triacylglycerols: an inquiry and analysis

Although stearic acid is a saturated fatty acid, its influence on plasma cholesterol acid other health variables is neutral; possibly owing in part to poor absorption. Reduced absorption of stearic acid from particular triacylglycerols, cocoa butter and novel fats formulated with short- and long-chain acid triacylglycerol molecules (Salatrims) has been attributed to high intakes. However, the circumstances and causes of poor stearic acid digestion from triacylglycerols are unclear; published data were therefore collected and analysed, with emphasis on human studies. Of twenty-eight studies conducted in adults, most are in men (>90%). The assertion that reduced absorption is due to a high intake of stearoyl groups is not supported: dietary intakes of stearoyl of 0·05–0·65 g stearic acid equivalent/kg body weight (cf typical intake of 0·2 g stearic acid equivalent/kg body weight in the Western diet) indicate that the ‘true’ digestibility of stearoyl is 0·98 (SE 0·01) g/g, with apparent digestibility less than this value at low intakes owing to endogenous stearic acid excretion and to inter-publication variation of unidentified cause. The neutral health impact of stearic acid must be due to factors other than availability. Exceptions include cocoa butter, Salatrims and tristearin, for which digestibility is an additional factor. The efficiency with which human subjects digest stearoyl from cocoa butter still remains uncertain, while the digestion of total long-chain fat from this source is 0·89–0·95 g/g, high in comparison with 0·33 g/g for Salatrim 23CA and 0·15 g/g for tristearin in their prepared states. Salatrims contain the highest proportion of long-chain fatty acids that are stearic acid-rich other than tristearin, which is the main component of fully-hydrogenated soyabean and rapeseed oil. Analysis shows that apparent digestibility of stearic acid is associated with stearoyl density within the triacylglycerol molecule and that, in Salatrims, the occurrence of short-chain fatty acids in place of long-chain fatty acids increases this density. Soap formation appears not to be a major factor in the reduced digestion of stearic acid from tristearin under regular dietary circumstances, but both microcrystallinity and reduced digestibility of tri-, di- and monostearoylglycerols appears to be important. Solubilisation of high-melting-point tristearin in low-melting-point oils improves the digestibility of its stearic acid, particularly when emulsified or liquidized at above melting point. However, without such artificial aids, the digestive tracts of the rat, dog and man have a low capacity for emulsifying and digesting stearic acid from tristearin. Reduced digestibility of stearic acid from Salatrim 23CA also appears to be attributable to reduced digestibility of di- and monostearoylglycerols and is particularly due to remnants with the 1- or 3-stearoylglycerol intact after initial hydrolytic cleavage. Short-chain organic acid in Salatrim 23CA, which is readily hydrolysed, leaves such remnants. Unlike tristearin, Salatrim 23CA melts at body temperature and mixing it with low-melting-point oils is not expected to cause further disruption of microcrystalline structures to aid digestibility of its stearoyl groups. The low digestibility of stearoyl in Salatrim 23CA, together with the occurrence of short-chain organic acids in this product, account for its relatively low nutritional energy value (about 20 kJ (5 kcal)/g) compared with traditional fats (37 kJ (9 kcal)/g) and low fat value (<20:37 kJ/kJ; <5:9 kcal/kcal) relative to traditional fats. In part these differences are because of minor effects of Salatrim 23CA on the excretion of other fat and protein, due to the bulking properties of this poorly-digestible fat.

Biochemical and toxicological studies on the effect of high and low erucic acid rapeseed oil on rats

Rats were fed on diets containing rapeseed oil, either containing low or high erucic acid content as well as the hydrogenated ones for 6 weeks. Body weight gain, biochemical and pathological parameters were investigated. The data showed high body weight gain for rats fed diets containing low erucic rape oil (LERo) compared with those fed either the high erucic rape oil (HERo), the hydrogenated or the partially hydrogenated oil diets. All rats showed non significant changes for total lipids, total cholesterol, GPT and GOT, except the partially hydrogenated rape oil diet which showed significant decrease for total cholesterol. Alkaline phosphatase however showed a significant decrease, while plasma phospholipids showed significant increase in rats fed on the hydrogenated oil diet. Triglycerides indicated non significant increase except in the group that received low erucic rape oil diet. Histopathological study showed changes in all tissues examined (liver and kidney).

A 91-day feeding study in rats with caprenin

Caprenin, a randomized triglyceride primarily comprising caprylic (C8:0), capric (C10:0), and behenic (C22:0) acids, was administered in a semi-purified diet to weanling Sprague-Dawley rats (25/sex/group) at dose levels of 5.23, 10.23 or 15.00% (w/w) for 91 days. Corn oil was added at 8.96, 5.91 and 3.00%, respectively, to provide essential fatty acids and digestible fat calories. Corn oil alone (12.14%) and a blend of medium-chain triglyceride (MCT) oil plus corn oil (11.21 and 3.13%, respectively) served as controls. All diets were formulated to provide about 4000 kcal/kg of diet and 26.8% of digestible calories from fat by assuming that corn oil, MCT oil, and caprenin provided 9, 7 and 5 kcal/g, respectively. Survival, clinical signs, body weight, feed consumption, feed efficiency, organ weights, organ-to-body-weight ratios, organ-to-brain-weight ratios, haematological values and clinical chemistry parameters were evaluated in all groups. Histopathology of a full complement of tissues was evaluated in the corn oil and MCT oil control groups as well as the high-dose caprenin group. Additional rats (n = 5/sex/group) were included in the study to determine whether there was marked storage of C22:0 in heart, liver or perirenal fat at the end of the 91-day feeding period. No significant differences in body weight gain were measured with the balanced caloric diets, although feed conversion efficiency was reduced in the high-dose caprenin group. No adverse effects from the ingestion of caprenin were detected, nor were significant amounts of C22:0 present in the fat extracted from the selected fat depot sites. These results establish a no-observable-adverse-effect level (NOAEL) of more than 15% (w/w) caprenin in the diet (or more than 83% of total dietary fat), which is equal to a mean exposure level of more than 13.2 g/kg/day for male rats and more than 14.6 g/kg/day for female rats.

Testing a short-term feeding trial to assess compositional and histopathological changes in hearts of rats fed vegetable oils

Male, female and castrated rats, three wk of age, were fed a low-fat diet for 14 wk followed by high-fat diets (20% by weight) for one wk containing graded levels of erucic acid from 1 to 50%, to evaluate the effect of short-term feeding and interaction of male sex hormones on formation of heart lesions. Some rats within each group were returned to the low-fat diet for one wk after the test period. For comparison, one group of three-wk-old male rats was fed the high fat 50% erucic acid diet for 15 wk. Erucic acid depressed growth rate and food consumption and increased cardiac lipidosis and triglycerides proportional to the erucic acid content of the diet. There were no sex differences, and the effects disappeared once rats were returned to the low-fat diet for one week. There was a significance (P less than 0.05) in the incidence of myocardial necrosis among male rats fed increased levels of erucic acid for one week, but the response was not linear to the increase in dietary erucic acid. Furthermore, the response was much less than in males fed the 50% erucic acid diet continually for 15 weeks. These results suggest that the short-term model is not a suitable substitute for the long-term feeding trial to test the cardiopathogenicity of a vegetable oil. The significantly lower incidence in myocardial lesions in female and castrated male rats compared with male rats suggests involvement of sex hormones.(ABSTRACT TRUNCATED AT 250 WORDS)

The methionine and choline status of rat diets and their effects on nutrition and myocardial lesions

This study evaluated for rats the nutritional adequacy of casein-based diets routinely used to test the cardiopathogenicity of vegetable oils. Diets were formulated containing 20% by weight casein, 20% soybean oil and graded levels of choline with and without methionine and were fed to male Sprague-Dawley rats for 16 weeks. Rats fed methionine-supplemented diets had improved growth and food consumption, increased liver lipids mainly in the form of triglycerides and normal amino acid metabolism. On the other hand, choline supplementation reduced liver lipids but had no effect on growth and feed consumption. The results would indicate that diets including 20% casein and 20% oil require methionine supplementation to assure the nutritional adequacy of this high caloric diet. However, in this study there was no evidence to indicate that choline or methionine supplementation affected the heart lesion incidence in male rats. It was therefore concluded that the amount and type of fat in the diet, not the choline and methionine status of the diet, is related to heart lesions in male rats.